NuuVim review
A rare same-price injectable/oral parity — $79/mo semaglutide, $133/mo tirzepatide either way — but that's a standing new-patient tier with an unpublished refill rate, its brand Ozempic and Zepbound run well above manufacturer self-pay pricing, and its own live site doesn't confirm the all-50-states claim found elsewhere.
- Independently scored
- Verified
Every medical claim in this piece is footnoted to the record it came from — the trial or the FDA label — so you can read the source rather than take the masthead's word for it. No one on this desk is your clinician.
NuuVim at a glance
- Semaglutide
- $79/mo
- Tirzepatide
- $133/mo
- Coverage
- Not disclosed by NuuVim's own live site — not verified by observation
- Brand-name
- Yes
How we scored NuuVim
Each factor is scored from NuuVim's real pricing, disclosures and oversight, then combined into the 64/100 Editors' Rating by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
Cost is unpredictable, premium, or hides behind a plan commitment.
Limited public detail on who oversees care and how.
The headline rate obscures a plan requirement or a hidden step-up.
Workable around a household, though it isn't built around one.
Support is thin once the prescription ships.
Leaving costs you — notice windows, minimum terms or fees you don't get back.
How we verified this review
- Last verified
- August 2026
- Confidence
- medium
- Primary source
- www.nuuvim.com
Live, real Texas-based DTC telehealth site. LegitScript-certified, HIPAA-compliant. States on-site that 'NuuVim does not manufacture compounded medications' — it outsources to a pharmacy rather than compounding in-house. Offers both semaglutide and tirzepatide as injectable AND oral at the same price — a genuinely uncommon parity. The $79/$133 'New GLP-1 Users' framing reads as a standing new-patient tier rather than a countdown-timer promo, but the site frames it that way itself and never publishes what a 'current user' (refill) pays afterward — that unpublished follow-on number is a real gap, not an invented one. Also lists brand Ozempic ($1,498/mo) and Zepbound ($1,892/mo), both priced well above LillyDirect/NovoCare's own manufacturer self-pay channels. States: WLR's directory asserts 'all 50 states plus DC,' but that claim could not be verified directly on NuuVim's own live site during this check — not repeated here as verified. Solid compounding disclaimer present verbatim: 'Compounded medications have not been evaluated or approved by the FDA for safety, efficacy, or quality.' No FDA warning letter found.
Pricing
Prices re-verified
| Medication | Monthly | Plan |
|---|---|---|
| Compounded semaglutide | $79 | Injectable or oral — New GLP-1 UsersPriced the same whether injectable or oral. A standing new-patient tier, not a countdown-timer promo — but NuuVim doesn't publish the follow-on 'current user' refill rate. |
| Compounded tirzepatide | $133 | Injectable or oral — New GLP-1 UsersSame injectable/oral price parity and new-patient-tier caveat as semaglutide. |
| Brand semaglutide | $1498 | Brand OzempicPriced far above LillyDirect/NovoCare-style manufacturer self-pay channels. |
| Brand tirzepatide | $1892 | Brand ZepboundSame pattern — well above manufacturer self-pay pricing. |
Swipe the table to see plan details →
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect NuuVim's public disclosures at last review and change often; confirm the current number on NuuVim's own site.
What we like
- Injectable and oral priced identically on both molecules — a real, uncommon needle-free option at no markup
- LegitScript-certified and HIPAA-compliant, with a clear, verbatim FDA compounding disclaimer
- One of the lowest new-patient headline prices on this roster
The caveats
- The $79/$133 figures are a new-patient tier; the follow-on refill price isn't published anywhere on-site
- Brand Ozempic ($1,498/mo) and Zepbound ($1,892/mo) both run far above the manufacturers' own self-pay programs
- A third-party directory's 'all 50 states + DC' claim could not be confirmed on NuuVim's own live site
NuuVim for mothers: our verdict
A rare same-price injectable/oral parity — $79/mo semaglutide, $133/mo tirzepatide either way — but that's a standing new-patient tier with an unpublished refill rate, its brand Ozempic and Zepbound run well above manufacturer self-pay pricing, and its own live site doesn't confirm the all-50-states claim found elsewhere. It runs about $79/month, flat across every dose — toward the affordable end of what we track.
We weigh NuuVim the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the parts a generic weight-loss review skips.
What NuuVim actually costs
- Compounded semaglutide — Injectable or oral — New GLP-1 Users: $79/mo
- Compounded tirzepatide — Injectable or oral — New GLP-1 Users: $133/mo
- Brand-name semaglutide — Brand Ozempic: $1498/mo
- Brand-name tirzepatide — Brand Zepbound: $1892/mo
That sits below the roughly $162 median ongoing price across the providers we track for mothers — a real cost advantage.
The medications NuuVim prescribes
NuuVim prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. It can route you to FDA-approved brand pens as well as compounded versions — the on-label products carry the manufacturer's own pregnancy and lactation labeling, which is cleaner to hand to an OB.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where NuuVim fits — and where it doesn't — for mothers
A good fit if…
- the real monthly cost is a real barrier and you want a low, predictable number.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
NuuVim is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: A mother who wants a genuinely needle-free option at no price penalty and will confirm the refill rate and her own state directly before committing past the first month.
Alternatives to NuuVim
Providers we have a referral relationship with, ordered by their Editors' Rating — highest first. A fee never moves a rating, but it does decide who appears here, so this is not the whole roster: the full ranking lists every provider we cover.
- Visit CoreAge RxCoreAge RxOur #1 pick
The one program on this masthead whose number still makes sense at the top of the dose. A flat, all-in monthly price on both molecules, no teaser rate to expire, and a cancel button you can actually find — the closest thing to a family-budget guarantee we've reviewed.
- Visit Gala Health
A flat $179 for either molecule and a genuinely gentle microdosing tier — a reasonable, all-doses-included option, if you can live with a yearly plan and a pharmacy the marketing never names.
- Visit Sesame
A high-trust telehealth marketplace that took a clear side: FDA-approved brand GLP-1 only, no compounded shortcut. You pay a brand cash price and book a real video visit — but you get on-label pens and one of the cleaner reputations on this masthead.
Keep comparing NuuVim
Head-to-head & alternatives
NuuVim, answered
- Is NuuVim's oral option really the same price as the injection?
- Yes — both semaglutide ($79/mo) and tirzepatide ($133/mo) are priced identically whether you take the injectable or oral form, a genuinely uncommon parity in this category, where oral routes usually cost more.
- Will NuuVim's price stay at $79 or $133 after the first month?
- That's the New GLP-1 Users price, framed as a standing new-patient tier rather than a limited-time promo — but NuuVim doesn't publish what the follow-on 'current user' refill rate actually is. Ask directly before assuming the intro number holds.
- Is brand-name Ozempic or Zepbound cheaper through NuuVim?
- No — NuuVim lists Ozempic at $1,498/mo and Zepbound at $1,892/mo, both well above what you'd pay through the manufacturers' own direct self-pay programs (LillyDirect, NovoCare). Compare both routes before choosing the brand path here.
- Does NuuVim serve all 50 states?
- A third-party directory claims all 50 states plus DC, but that could not be confirmed directly on NuuVim's own live site as of this check — treat it as unconfirmed and ask directly.
Pricing, states and verification reflect NuuVim's public disclosures at last review; the Editors' Rating is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.